This gene encodes a member of the epidermal growth factor (EGF) receptor family of receptor tyrosine kinases. This protein has no ligand binding domain of its own and therefore cannot bind growth factors. However, it does bind tightly to other ligand-bound EGF receptor family members to form a heterodimer, stabilizing ligand binding and enhancing kinase-mediated activation of downstream signalling pathways, such as those involving mitogen-activated protein kinase and phosphatidylinositol-3 kinase. Allelic variations at amino acid positions 654 and 655 of isoform a (positions 624 and 625 of isoform b) have been reported, with the most common allele, Ile654/Ile655, shown here. Amplification and/or overexpression of this gene has been reported in numerous cancers, including breast and ovarian tumors. Alternative splicing results in several additional transcript variants, some encoding different isoforms and others that have not been fully characterized. [provided by RefSeq, Jul 2008].
Rovati, Mariucci, Delfanti, Grasso, Tinelli, Torre, De Amici, Pedrazzoli: "Simultaneous detection of circulating immunological parameters and tumor biomarkers in early stage breast cancer patients during adjuvant chemotherapy." in: Cellular oncology (Dordrecht), Vol. 39, Issue 3, pp. 211-28, (2017) (PubMed).
Laidi, Bouziane, Lakhdar, Khabouze, Rhrab, Zaoui: "Salivary expression of soluble HER2 in breast cancer patients with positive and negative HER2 status." in: OncoTargets and therapy, Vol. 7, pp. 1285-9, (2014) (PubMed).
Zhang, Zhao, Wu, Kong, Sun, Cao, Zhang, Wang, Zhang, Jin, Li: "Therapeutic effect of co-transplantation of neuregulin-1-transfected Schwann cells and bone marrow stromal cells on spinal cord hemisection syndrome." in: Neuroscience letters, Vol. 497, Issue 2, pp. 128-33, (2011) (PubMed).
Tao, Suhua, Juanjuan, Zongzhi, Juan, Dandan: "In vitro study on human cytomegalovirus affecting early pregnancy villous EVT's invasion function." in: Virology journal, Vol. 8, pp. 114, (2011) (PubMed).